Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 15, 2020, after the close
10-Q filed May 15, 2020, 45 days after period end · 0001171843-20-003750
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $6.02K | $2.50K | $2.50K | $2.50K |
| Net Income | -$2.38M | -$3.11M | -$2.15M | -$7.57M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$5.58 |
| -$3.42 |
| -$0.14 |
| -$0.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
